share_log

Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results

SEC ·  Feb 28, 2023 14:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more